Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Business & Industry
- Merck initiates first clinical trial of TLR7 and 8 inhibitor as a potential treatment for severe symptoms of COVID-19 infection
- Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US
- Pfizer and BioNTech announce early positive data from an ongoing Phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
- Lilly begins world's first study of a potential COVID-19 antibody treatment in humans
- GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials
Research & Development
- Newer variant of COVID-19-causing virus dominates global infections
- Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction
- Whole-town study reveals more than 40% of COVID-19 infections had no symptoms
- Even in the worst COVID-19 cases, the body launches immune cells to fight back
- Existing drugs can prevent SARS-CoV-2 from hijacking cells
- Study is first to identify potential therapeutic targets for COVID-19
- Initial COVID-19 infection rate may be 80 times greater than originally reported
Conferences & Events
- Wearable Injectors and Connected Devices Conference 2020
- Preparing for the new world of drug safety: Embracing cloud and AI
- Pre-filled Syringes San Francisco Conference 2020
- Oligonucleotide Therapeutics and Delivery Conference 2020
- Pre-Filled Syringes West Coast 2021
- Pre-Filled Syringes East Coast Conference 2020
- SMi's 4th Annual Pharmaceutical Microbiology West Coast
Regulatory Affairs
- FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
- FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
- Global regulators commit to cooperate on observational research in the context of COVID-19
- FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19